Page last updated: 2024-09-02

fr 139317 and Diabetes Mellitus, Type 2

fr 139317 has been researched along with Diabetes Mellitus, Type 2 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bratz, IN; Damron, DS; Guarini, G; Haney, RM; Meszaros, JG; Ohanyan, VA; Raman, P; Talasila, PK; Thodeti, CK1

Other Studies

1 other study(ies) available for fr 139317 and Diabetes Mellitus, Type 2

ArticleYear
Endothelin-mediated in vivo pressor responses following TRPV1 activation.
    American journal of physiology. Heart and circulatory physiology, 2011, Volume: 301, Issue:3

    Topics: Adrenergic alpha-Agonists; Analysis of Variance; Animals; Azepines; Biphenyl Compounds; Blood Pressure; Capsaicin; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptides; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Femoral Artery; Indoles; Infusions, Intravenous; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenylephrine; Receptor, Endothelin A; Receptor, Endothelin B; TRPV Cation Channels; Vasoconstriction; Vasoconstrictor Agents

2011